Salman Malik, MD
Clinical Cardiac Electrophysiology · Glen Burnie, MDNPI 1326132101
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $778 of the $1,232 with a category attached, or 63.2%. 17 manufacturers reported payments, led by Boston Scientific at 30.2% of the total. Reporting peaked in 2023 at $356 and has fallen 53.8% since, to $165 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in MD, where the typical reported total is $15,262.
Across 27 payments — averaging $45.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$372
- Novo Nordisk$232
- Vifor Pharma, Inc.$200
- Lantheus Medical Imaging, Inc.$60
- Regeneron Healthcare Solutions, Inc.$54
- AstraZeneca$50
- plus $264 from 11 others
What the payments were for
- Speaking & faculty fees$20016%
- Food & beverage$77863%
- Education$25421%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 4 | $372 |
| Novo Nordisk | 1 | $232 |
| Vifor Pharma, Inc. | 1 | $200 |
| Lantheus Medical Imaging, Inc. | 2 | $60 |
| Regeneron Healthcare Solutions, Inc. | 3 | $54 |
| AstraZeneca | 3 | $50 |
| Amarin Pharma, Inc. | 2 | $36 |
| Pfizer | 2 | $36 |
| Johnson & Johnson | 1 | $31 |
| Irhythm Technologies, Inc. | 1 | $25 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $24 |
| Novartis | 1 | $23 |
| Merck | 1 | $22 |
| Amryt Pharma Holdings Ltd | 1 | $18 |
| Amgen | 1 | $17 |
| Philips North America LLC | 1 | $17 |
| Abbott | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$232
- Veltassa$200
- WATCHMAN Access System$142
- EMBLEM MRI S-ICD$111
How this compares
$1,232 in reported general payments places this provider in the 10th percentile of 63 clinical cardiac electrophysiology providers in Maryland.
See all clinical cardiac electrophysiology providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 254 | $365,629 |
| JardianceEmpagliflozin | 135 | $180,714 |
| EntrestoSacubitril/Valsartan | 86 | $116,047 |
| XareltoRivaroxaban | 66 | $80,311 |
| MultaqDronedarone Hcl | 39 | $66,845 |
| Ezetimibe | 378 | $20,725 |
| Rosuvastatin Calcium | 510 | $15,575 |
| Repatha SureclickEvolocumab | 17 | $12,360 |
| VascepaIcosapent Ethyl | 13 | $10,858 |
| Metoprolol Succinate | 461 | $9,682 |
| Atorvastatin Calcium | 427 | $6,637 |
| Icosapent Ethyl | 15 | $5,992 |
| Amiodarone Hcl | 72 | $3,951 |
| Carvedilol | 315 | $3,914 |
| Losartan Potassium | 236 | $3,802 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $36 | $365,629254 claims |
| NovartisEntresto | $23 | $116,04786 claims |
| Johnson & JohnsonXarelto | $31 | $80,31166 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 10th percentile of 63 clinical cardiac electrophysiology providers in Maryland.
Other clinical cardiac electrophysiology in Glen Burnie
- Andrew ZohlmanGlen Burnie$6K
- Sean BeinartRockville$315K
- Charles LoveBaltimore$238K
- Hugh CalkinsBaltimore$202K
- Paresh ShahBaltimore$97K
- Helen BaroldRockville$83K
- Jonathan ChrispinBaltimore$77K
- Sung LeeTakoma Park$68K
- Stephen ShorofskyBaltimore$63K
- Nilofar IslamTowson$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.